Search tool

Displaying 931 - 940 of 999

Conduct a field trial of implementation of a standard protocol to collect information on treatment demand in the EU Member States

This report presents the results and findings of a field trial conducted in 1999 on the treatment demand indicator. This field trial was conducted as part of a project which had the...

Guidelines for the prevalence of problem drug use (PDU) key indicator at local level

Prevalence of problem drug use (PDU) is one of five key indicators used by the EMCDDA to provide more comparable, scientifically based estimates of the prevalence of more severe patterns of drug...

Work programme 2000

Summary: The work programme for 2000 of the EMCDDA aimed to accomplish the implementation of its second three year work programme, Three-year work programme 1998–2000, with the view to preparing the next...

1999 Annual report on the state of the drugs problem in the European Union

The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in...

1999 Extended annual report on the state of the drugs problem in the European Union

The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in...

Drugnet Europe 20

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and...

Drugnet Europe 19

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and...

publication thumbnail

Review and synthesis of scientific literature on drug-related non-fatal emergencies

The aim of this report was to provide a detailed review of epidemiological studies on drug-related emergencies implemented recently (10 years) in the European Union, and to synthesise information generated by all...

Guidelines for the risk assessment of new synthetic drugs

This publication was drawn up by the steering group created by the EMCDDA's Scientific Committee in November 1998 to establish guidelines to assess the risks of all new synthetic drugs identified under...

Drugnet Europe 18

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and...